Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Genome Biol ; 25(1): 187, 2024 Jul 10.
Article in English | MEDLINE | ID: mdl-38987807

ABSTRACT

Characterizing the binding preferences of transcription factors (TFs) in different cell types and conditions is key to understand how they orchestrate gene expression. Here, we develop TFscope, a machine learning approach that identifies sequence features explaining the binding differences observed between two ChIP-seq experiments targeting either the same TF in two conditions or two TFs with similar motifs (paralogous TFs). TFscope systematically investigates differences in the core motif, nucleotide environment and co-factor motifs, and provides the contribution of each key feature in the two experiments. TFscope was applied to > 305 ChIP-seq pairs, and several examples are discussed.


Subject(s)
Chromatin Immunoprecipitation Sequencing , Machine Learning , Transcription Factors , Transcription Factors/metabolism , Binding Sites , Humans , Nucleotide Motifs , Protein Binding
2.
Nucleic Acids Res ; 49(5): 2488-2508, 2021 03 18.
Article in English | MEDLINE | ID: mdl-33533919

ABSTRACT

The ubiquitous family of dimeric transcription factors AP-1 is made up of Fos and Jun family proteins. It has long been thought to operate principally at gene promoters and how it controls transcription is still ill-understood. The Fos family protein Fra-1 is overexpressed in triple negative breast cancers (TNBCs) where it contributes to tumor aggressiveness. To address its transcriptional actions in TNBCs, we combined transcriptomics, ChIP-seqs, machine learning and NG Capture-C. Additionally, we studied its Fos family kin Fra-2 also expressed in TNBCs, albeit much less. Consistently with their pleiotropic effects, Fra-1 and Fra-2 up- and downregulate individually, together or redundantly many genes associated with a wide range of biological processes. Target gene regulation is principally due to binding of Fra-1 and Fra-2 at regulatory elements located distantly from cognate promoters where Fra-1 modulates the recruitment of the transcriptional co-regulator p300/CBP and where differences in AP-1 variant motif recognition can underlie preferential Fra-1- or Fra-2 bindings. Our work also shows no major role for Fra-1 in chromatin architecture control at target gene loci, but suggests collaboration between Fra-1-bound and -unbound enhancers within chromatin hubs sometimes including promoters for other Fra-1-regulated genes. Our work impacts our view of AP-1.


Subject(s)
Enhancer Elements, Genetic , Gene Expression Regulation, Neoplastic , Proto-Oncogene Proteins c-fos/metabolism , Triple Negative Breast Neoplasms/genetics , Binding Sites , Cell Line, Tumor , Chromatin/chemistry , Chromatin/metabolism , Epigenesis, Genetic , Fos-Related Antigen-2/metabolism , Humans , Nucleotide Motifs , Promoter Regions, Genetic , Proto-Oncogene Proteins c-fos/physiology , Transcription Factor AP-1/metabolism , Triple Negative Breast Neoplasms/metabolism , p300-CBP Transcription Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...